Nexogen, Inc.

Nexogen, Inc. is a San Diego-based biotechnology company founded in 2009 that specializes in developing rapid DNA and RNA diagnostic technologies for point-of-need applications. The company creates integrated diagnostic instruments and platforms that incorporate microfluidics, proprietary extraction methods, and accelerated biomolecular reactions using electric and magnetic fields. Key products include the NEXI-Dx, a microfluidic-based isothermal amplification platform; the CAS-100, an automated sample-to-answer system utilizing carbon array technology; and the NEXI-SP, a portable DNA extraction device. These tools are designed to streamline sample processing, amplification, and detection, typically delivering results in minutes rather than hours.

These solutions are intended to improve diagnostic accessibility in human and veterinary clinical settings, such as emergency rooms, urgent care clinics, and small hospitals. By providing rapid, low-complexity, and affordable molecular diagnostics, Nexogen aims to enable the quick identification and management of infectious diseases, respiratory conditions, and other health threats before they spread. The company has engaged in research and development collaborations with organizations such as DARPA and the NIH to validate its platforms and advance diagnostic capabilities for both medical and agricultural use cases.